Xiaochong Gao1, Garrett Gotway2, Karl Rathjen3, Charles Johnston3, Steven Sparagana4, Carol A Wise5. 1. Sarah M. and Charles E. Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, 2222 Welborn St., Dallas, TX 75219, USA. 2. Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA. 3. Department of Orthopedic Surgery, Texas Scottish Rite Hospital for Children, Dallas, TX, USA; Department of Orthopaedic Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA. 4. Department of Neurology, Texas Scottish Rite Hospital for Children, Dallas, TX, USA; Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, USA. 5. Sarah M. and Charles E. Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, 2222 Welborn St., Dallas, TX 75219, USA; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Orthopaedic Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA; McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: Carol.Wise@tsrh.org.
Abstract
STUDY DESIGN: To test for rare genetic mutations, a cohort of patients with unexplained early-onset scoliosis (EOS) was screened using high-density microarray genotyping. A cohort of patients with adolescent idiopathic scoliosis (AIS) was similarly screened and the results were compared. SUMMARY OF BACKGROUND DATA: Patients with scoliosis in infancy or early childhood (EOS) are at high risk for progressive deformity and associated problems including respiratory compromise. Early-onset scoliosis is frequently associated with genetic disorders but many patients present with nonspecific clinical features and without an associated diagnosis. The authors hypothesized that EOS in these patients may be caused by rare genetic mutations detectable by next-generation genomic methods. METHODS: The researchers identified 24 patients with unexplained EOS from pediatric orthopedic clinics. They genotyped them, along with 39 connecting family members, using the Illumina OmniExpress-12, version 1.0 beadchip. Resulting genotypes were analyzed for chromosomal changes, specifically copy number variation and absence of heterozygosity. They screened 482 adolescent idiopathic scoliosis (AIS) patients and 744 healthy controls, who were similarly genotyped with the same beadchip, for chromosomal changes identified in the EOS cohort. RESULTS: Copy number variation and absence of heterozygosity analyses revealed a genetic diagnosis of chromosome 15q24 microdeletion syndrome in 1 patient and maternal uniparental disomy of chromosome 14 in a second one. Prior genetic testing and clinical evaluations had been negative in both cases. A large novel chromosome 10 deletion was likely causal in a third EOS patient. These mutations identified in the EOS patients were absent in AIS patients and controls, and thus were not associated with AIS or found in asymptomatic individuals. CONCLUSIONS: These data underscore the usefulness of updated genetic evaluations including high-density microarray-based genotyping and other next-generation methods in patients with unexplained EOS, even when prior genetic studies were negative. These data also suggest the intriguing possibility that other mutations detectable by whole genome sequencing, as well as epigenetic effects, await discovery in the EOS population.
STUDY DESIGN: To test for rare genetic mutations, a cohort of patients with unexplained early-onset scoliosis (EOS) was screened using high-density microarray genotyping. A cohort of patients with adolescent idiopathic scoliosis (AIS) was similarly screened and the results were compared. SUMMARY OF BACKGROUND DATA: Patients with scoliosis in infancy or early childhood (EOS) are at high risk for progressive deformity and associated problems including respiratory compromise. Early-onset scoliosis is frequently associated with genetic disorders but many patients present with nonspecific clinical features and without an associated diagnosis. The authors hypothesized that EOS in these patients may be caused by rare genetic mutations detectable by next-generation genomic methods. METHODS: The researchers identified 24 patients with unexplained EOS from pediatric orthopedic clinics. They genotyped them, along with 39 connecting family members, using the Illumina OmniExpress-12, version 1.0 beadchip. Resulting genotypes were analyzed for chromosomal changes, specifically copy number variation and absence of heterozygosity. They screened 482 adolescent idiopathic scoliosis (AIS) patients and 744 healthy controls, who were similarly genotyped with the same beadchip, for chromosomal changes identified in the EOS cohort. RESULTS: Copy number variation and absence of heterozygosity analyses revealed a genetic diagnosis of chromosome 15q24 microdeletion syndrome in 1 patient and maternal uniparental disomy of chromosome 14 in a second one. Prior genetic testing and clinical evaluations had been negative in both cases. A large novel chromosome 10 deletion was likely causal in a third EOS patient. These mutations identified in the EOS patients were absent in AISpatients and controls, and thus were not associated with AIS or found in asymptomatic individuals. CONCLUSIONS: These data underscore the usefulness of updated genetic evaluations including high-density microarray-based genotyping and other next-generation methods in patients with unexplained EOS, even when prior genetic studies were negative. These data also suggest the intriguing possibility that other mutations detectable by whole genome sequencing, as well as epigenetic effects, await discovery in the EOS population.
Authors: Nandina Paria; Lawson A Copley; John A Herring; Harry K W Kim; B Stephens Richards; Daniel J Sucato; Jonathan J Rios; Carol A Wise Journal: J Bone Joint Surg Am Date: 2014-03-05 Impact factor: 5.284
Authors: David T Miller; Margaret P Adam; Swaroop Aradhya; Leslie G Biesecker; Arthur R Brothman; Nigel P Carter; Deanna M Church; John A Crolla; Evan E Eichler; Charles J Epstein; W Andrew Faucett; Lars Feuk; Jan M Friedman; Ada Hamosh; Laird Jackson; Erin B Kaminsky; Klaas Kok; Ian D Krantz; Robert M Kuhn; Charles Lee; James M Ostell; Carla Rosenberg; Stephen W Scherer; Nancy B Spinner; Dimitri J Stavropoulos; James H Tepperberg; Erik C Thorland; Joris R Vermeesch; Darrel J Waggoner; Michael S Watson; Christa Lese Martin; David H Ledbetter Journal: Am J Hum Genet Date: 2010-05-14 Impact factor: 11.025
Authors: Duncan B Sparrow; Gavin Chapman; Allanceson J Smith; Muhammad Z Mattar; Joelene A Major; Victoria C O'Reilly; Yumiko Saga; Elaine H Zackai; John P Dormans; Benjamin A Alman; Lesley McGregor; Ryoichiro Kageyama; Kenro Kusumi; Sally L Dunwoodie Journal: Cell Date: 2012-04-05 Impact factor: 41.582
Authors: Ayman W El-Hattab; Teresa A Smolarek; Martha E Walker; Elizabeth K Schorry; LaDonna L Immken; Gayle Patel; Mary-Alice Abbott; Brendan C Lanpher; Zhishuo Ou; Sung-Hae L Kang; Ankita Patel; Fernando Scaglia; James R Lupski; Sau Wai Cheung; Pawel Stankiewicz Journal: Hum Genet Date: 2009-06-26 Impact factor: 4.132
Authors: Wenjing Lai; Xin Feng; Ming Yue; Prudence W H Cheung; Vanessa N T Choi; You-Qiang Song; Keith D K Luk; Jason Pui Yin Cheung; Bo Gao Journal: Genes (Basel) Date: 2021-08-05 Impact factor: 4.096
Authors: Trenell J Mosley; H Richard Johnston; David J Cutler; Michael E Zwick; Jennifer G Mulle Journal: BMC Med Genomics Date: 2021-06-09 Impact factor: 3.063
Authors: Elisabet Einarsdottir; Anna Grauers; Jingwen Wang; Hong Jiao; Stefan A Escher; Aina Danielsson; Ane Simony; Mikkel Andersen; Steen Bach Christensen; Kristina Åkesson; Ikuyo Kou; Anas M Khanshour; Acke Ohlin; Carol Wise; Shiro Ikegawa; Juha Kere; Paul Gerdhem Journal: PLoS One Date: 2017-12-14 Impact factor: 3.240